Clinical studies

Currently we run 2 clinical trials with patients with prostate cancer. Preliminary data suggest that the single drug injection results in induction of biological markers confirming mechanism of action and suggesting therapeutic effect of Mobilan (М-VM3). Additionally, the drug is well tolerated and safe in the range of the studied doses.

To know more about the Mobilan study:

https://clinicaltrials.gov/ct2/show/NCT02844699?term=M-VM3&rank=2

http://grls.rosminzdrav.ru/CiPermitionReg.aspx?DateBeg=&DateEnd=&DateInc=&NumInc=&RegNm=&Statement=&Protocol=&Torg=мобилан&LFDos=&Qualifier=&Producer=&Recearcher=&OrgDocOut=2&Status=1&NotInReg=0&All=0&PageSize=8&order=date_perm&orderType=desc&pagenum=1